grant

Multicentre, open label, randomised, controlled trial of severe ARF management with an augmented vs normal CRRT regimen [ 2005 - 2008 ]

Also known as: The RENAL (Randomised Evaluation of Normal vs Augmented Level) Replacement Therapy in ICU Study.

Research Grant

[Cite as http://purl.org/au-research/grants/nhmrc/352550]

Researchers: Prof Simon Finfer (Principal investigator) ,  A/Pr Carlos Scheinkestel Dr Catherine Cole Prof Alan Cass Prof John Myburgh
View all 6 related researchers

Brief description Sudden serious kidney failure is a major problem that frequently occurs in patients who are in Intensive Care. For these patients, their chances of survival are significantly decreased. In Australia sudden serious kidney failure is usually treated with continuous kidney support by a kidney machine. A recent study found that by using greater than normal levels of kidney support, that is , running larger volumes of fluid through the kidney machine, patients in Intensive Care Units (ICU's) may be less likely to die from their sudden serious kidney failure. Despite these positive findings, this high level of kidney support is not commonly used in Australian ICU's. Clearly though, if greater than normal levels of kidney support do increase the chances that individuals will live, then patients should be receiving this treatment. The Australia and New Zealand Intensive Care Society, in conjunction with The George Institute for International Health, propose to conduct a new study involving 1500 patients from ICU's throughout Australia, who require continuous kidney support due to sudden serious kidney failure. These patients will be randomly assigned so that half receive the normally used levels of kidney support and the other half receive kidney support at greater than normal levels. Patients will then be followed for three months to compare the proportions of patients who die in each group. All other outcomes and serious side effects will be closely monitored throughout the study. The results will be available to the public within four years of starting the study, and these are likely to influence the treatment of patients admitted to ICU's with sudden serious kidney failure, not only in Australia but also worldwide.

Funding Amount $AUD 1,879,125.00

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]